Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
572.24B
Market cap572.24B
Price-Earnings ratio
21.76
Price-Earnings ratio21.76
Dividend yield
2.17%
Dividend yield2.17%
Average volume
7.18M
Average volume7.18M
High today
$240.42
High today$240.42
Low today
$237.01
Low today$237.01
Open price
$239.79
Open price$239.79
Volume
2.46M
Volume2.46M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$146.12
52 Week low$146.12

Stock Snapshot

With a market cap of 572.24B, Johnson & Johnson(JNJ) trades at $237.58. The stock has a price-to-earnings ratio of 21.76 and currently yields dividends of 2.2%.

On 2026-04-15, Johnson & Johnson(JNJ) stock traded between a low of $237.01 and a high of $240.42. Shares are currently priced at $237.58, which is +0.2% above the low and -1.2% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 2.46M, against a daily average of 7.18M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.

JNJ News

TipRanks 4h
Johnson & Johnson price target raised to $254 from $253 at BofA

BofA raised the firm’s price target on Johnson & Johnson to $254 from $253 and keeps a Neutral rating on the shares following what the firm calls “an okay 1Q pr...

TipRanks 17h
Johnson & Johnson Bets Big on Next-Gen Growth

Johnson & Johnson ((JNJ)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and po...

CNBC 23h
J&J is off to a strong start in 2026 — here's how our newest stock can build on it

Johnson & Johnson on Tuesday validated our decision to make it our newest Club stock, delivering a beat-and-raise quarter led by its most important growth medic...

J&J is off to a strong start in 2026 — here's how our newest stock can build on it

Analyst ratings

59%

of 29 ratings
Buy
58.6%
Hold
34.5%
Sell
6.9%

More JNJ News

24/7 Wall St. 1d
Johnson and Johnson Raises Dividend for 64th Consecutive Year

Johnson and Johnson Raises Dividend for 64th Consecutive Year By Joel South Published Apr 14, 12:55PM EDT Quick Read Johnson & Johnson (JNJ) raised its quarte...

Johnson and Johnson Raises Dividend for 64th Consecutive Year
Benzinga 1d
Johnson & Johnson Q1 2026 Earnings Call Transcript

Good morning and welcome to Johnson & Johnson’s first quarter 2026 earnings conference call. All participants will be in the listen only mode until the question...

Johnson & Johnson Q1 2026 Earnings Call Transcript
Nasdaq 1d
Dow Analyst Moves: JNJ

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...

Dow Analyst Moves: JNJ
Nasdaq 1d
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #10 broker pick, on average, out of the 30 stocks m...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Simply Wall St 1d
Johnson & Johnson Dividend Streak Extends As New Therapies Support Outlook

Johnson & Johnson (NYSE:JNJ) announced its 64th consecutive annual dividend increase, with a 3.1% raise. The company highlighted new product updates, including...

Johnson & Johnson Dividend Streak Extends As New Therapies Support Outlook
Benzinga 1d
Johnson & Johnson Q1 Performance: Cancer Drug Revenue Grows, Free Cash Flow Falls, Hikes Dividend

Johnson & Johnson (NYSE:JNJ) on Tuesday reported a first-quarter 2025 adjusted earnings of $2.70 per share, down 2.5% year over year, beating the consensus of $...

Johnson & Johnson Q1 Performance: Cancer Drug Revenue Grows, Free Cash Flow Falls, Hikes Dividend
Investor's Business Daily 1d
Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance

Technology Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance Licensing Johnson & Johnson (JNJ) stock fell early Tuesday after the Dow Jo...

Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.